Legacy Financial Advisors, Inc. Gilead Sciences, Inc. Transaction History

Legacy Financial Advisors, Inc.

$515 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $437,926 - $534,040	-6,118 Reduced 59.23%	4,211 $308,000
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $50,116 - $56,833	684 Added 7.09%	10,329 $836,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1,330 - $1,452	18 Added 0.19%	9,645 $722,000
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $71,125 - $81,033	-920 Reduced 8.72%	9,627 $798,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $102,890 - $147,714	1,651 Added 18.56%	10,547 $905,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $14,944 - $17,070	251 Added 2.9%	8,896 $549,000
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $64,530 - $72,681	1,118 Added 14.85%	8,645 $534,000
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $57,572 - $72,144	-994 Reduced 11.67%	7,527 $447,000
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $31,466 - $35,715	485 Added 6.04%	8,521 $619,000
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $40,004 - $43,160	591 Added 7.94%	8,036 $561,000
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $41,953 - $45,840	661 Added 9.74%	7,445 $513,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $48,180 - $54,973	803 Added 13.43%	6,784 $438,000
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $21,583 - $24,593	381 Added 6.8%	5,981 $348,000
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $347,760 - $437,248	5,600 New	5,600 $354,000
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $20,045 - $22,479	-324 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $10,317 - $11,558	-165 Reduced 33.74%	324 $21,000
Q4 2018 Jan 16, 2019	BUY	$60.54 - $79.0 $23,186 - $30,257	383 Added 361.32%	489 $31,000
Q3 2018 Oct 30, 2018	BUY	$71.28 - $78.92 $5,346 - $5,919	75 Added 241.94%	106 $8,000
Q2 2018 Jul 17, 2018	SELL	$64.88 - $75.68 $10,056 - $11,730	-155 Reduced 83.33%	31 $2,000
Q1 2018 Apr 12, 2018	BUY	$72.84 - $88.8 $364 - $444	5 Added 2.76%	186 $13,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $12,878 - $15,117	181	181 $12,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.

Account